Description
Blinatumomab: new hope for patients with relapsed/refractory acute lymphoblastic leukemia
Article: Blinatumomab: new hope for patients with relapsed/refractory acute lymphoblastic leukemia
€3.03
Related products
-
Article: Highlights in breast cancer
€3.03 Add to cart -
Article: Highlights in genitourinary cancers
€3.03 Add to cart -
Article: Highlights in squamous cell carcinoma of the head and neck
€3.03 Add to cart -
1 year subscription print edition of the Belgian Journal of Hematology (BJH)
€209.83 Add to cart
